Pietro Genovese, PhD, on Using Base-Editing to Protect Healthy Stem Cells from Immunotherapy Toxicity
The principal investigator at the Gene Therapy Program of Dana-Farber/Boston Children’s Cancer and Blood Disorder Center discussed innovative uses of gene editing technology.